Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-06-02 @ 10:59 AM
Study NCT ID:
NCT04860960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2021-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
Sponsor:
Cyclo Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Niemann-Pick Disease, Type C1 | View |